Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — FY2025 Earnings Presentation
40 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Feb 17, 2026
Slide 1: FY 2025 Earnings Call Presentation
FY 2025 Earnings Call Presentation As of 17 February 2026
Slide 2: Presenting Team
Presenting Team Ziyad Al Dahami Faisal Al Nassar Esam Al Mashloum Head of Investor Relations and Treasury Chief Executive Officer Vice President, Finance FY 2025 HMG Investor Presentation
Slide 3: Agenda
Agenda 1 Financial Performance 2 Projects Update 3 Q&A Key Financial Highlights 5 Projects Update – Completed Projects 12 Q&A 14 Balance Sheet Highlights 6 Projects Update – Future Projects 13 Financial Performance Indictors 7 Leverage Levels 8 Declared Cash Dividends 9 2025 Patient Overview 10 Appe
Slide 4: Financial Performance
1 Financial Performance
Slide 5: Key Financial Highlights: FY 2025
Key Financial Highlights: FY 2025 Gross Profit 12.36% Gross Profit Margin % FY 2025 4,207 FY 2025 30.69% FY 2024 3,744 FY 2024 33.43% EBITDA 17.86% EBITDA Margin % 25.59% FY 2025 3,507 FY 2025 26.57% FY 2024 2,975 FY 2024 Net Income 3.72% Net Income Margin % 17.52% FY 2025 2,401 FY 2025 20.67% FY 20
Slide 6: Balance Sheet Highlights
Balance Sheet Highlights Total Assets as at 31-December 5.4% 14.06% 6.99% Cash and bank Account Receivable 9.83% Account Receivable 1.11 Cash and bank 2.89 4.12% 1.62 Inventories 2.28 4.43% 37.03% Inventories Equity 0.85 36.33% Equity 1.03 7.61 2024 2024 8.43 Total Assets 2.29% 2025 20.56 Other Curr
Slide 7: Financial Performance Indicators: FY 2025
Financial Performance Indicators: FY 2025 ROE Current Ratio Inventory 31.86% 1.15x 36 Days 33.90% 1.28x 34 ROA Receivables Cash Cycle 10.97% 36 Days (2) Days 12.74% 30 (12) ROCE Payables 15.02% 74 Days 76 FY 2025 FY 2024 16.31% Increase Decrease The same range 7 FY 2025 HMG Investor Presentation
Slide 8: Leverage Levels
Leverage Levels 120.00% Total liabilities and equity million Liabilities/Total Assets Liabilities/Equity 100.00% 0.64x 1.75x FY 2025 FY 2025 FY 2024 0.63x FY 2024 1.70x 80.00% 37.03% 36.33% 7,613 8,429 60.00% Debt / Equity Net Debt / EBITDA FY 2025 1.11x FY 2025 2.02x 40.00% 1.08x FY 2024 1.79x FY 2
Slide 9: Declared Cash Dividends
Declared Cash Dividends Declared Dividends Pay-out 1.31 per share 458.50 mn 70.4% Declared Cash Dividends – Q4 2025 1.21 per share 423.50 mn 70.3% 2025 Current Capital 3.5 billion 1.19 1.12per pershare share 416.5 mn 70.5% Number of Shares 350 million 1.12 per share 392.0 mn 70.4% Dividend to be Dis
Slide 10: Highlights: 2025 Patient Overview
Highlights: 2025 Patient Overview FY 2025 FY 2024 10 FY 2025 HMG Investor Presentation
Slide 11: Projects Update
2 Projects Update
Slide 12: Projects Update – Completed Projects
Projects Update – Completed Projects Solidifying our market leadership through robust expansion plans and progressing our projects 2024 Al Fayhaa Hospital Women’s Health Al Sahafa Hospital Hospital Ownership Ownership Ownership 50% 100% 100% Jeddah Riyadh Riyadh Opened on Opened on Opened on March 2
Slide 13: Projects Update – Future Projects
Projects Update – Future Projects Solidifying our market leadership through robust expansion plans and progressing our projects Tabuk Hospital Jubail Industrial City Hospital Red Sea Hospital Leased Leased Agreement Agreement Operating and Land Management Land Contract Jubail Tabuk Industrial Red Se
Slide 14: Q&A
3 Q&A OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Slide 15: Appendix #1 Operational Highlights
4 Appendix #1 Operational Highlights
Slide 16: FY 2025 Highlights
FY 2025 Highlights Opened new medical facilities: New project announcements: Cooperation agreement with Universities: • Hamra Hospital • Signed contracts with AMAALA Company and • University of Jeddah to support training, • Khobar Medical Center Red Sea Real Estate Company to operate, employment, an
Slide 17: Medical Excellence
Medical Excellence Creating the medical practitioners of the future and promoting health and well-being Continuous Medical Research Center Postgraduate Program Education 4 Journal issued 385+ Activities 780+ Hours 51 85+ research paper published Residency & Fellowship program in 180 Research proposa
Slide 18: ESG and Sustainability
ESG and Sustainability Group-Wide Decarbonization Plan: Developed and formalized a structured Comprehensive ESG Risk Assessment: Conducted a Group-wide ESG risk assessment, including Decarbonization Plan outlining a clear pathway to reduce Scope 1 and Scope 2 a dedicated climate risk assessment, to
Slide 19: Our People
Our People We continue to attract and retain top talent 67% female Physician Qualifications 29,400+ Workforce 33% male Staff ratio 46% 5,900+ 90%+ Physicians Retention Rate 26% 90+ 36% Nationalities Saudization 28% Training via Virtual Academy Platform Saudi Western (Including North America and UK)
Slide 20: HMG App and Investor Relations
HMG App and Investor Relations HMG App Highlight Engagement with Investment Community Interaction 46% Booked 32% 185+ Investors and analyst meetings Appointments 235+ Individuals attended the meetings +1.0b +6.47m 3 Attended conferences interactions appointments 22 Analysts coverage Year-End Market
Slide 21: Recognitions
Recognitions Accreditations Joint Commission College of American Best Practice in Global Health Accreditation International Accreditation Pathology (CAP) Vitrification Recognition (GHA) (JCIA) Health Information Association for the Advancement of Management System Society, Council Health Insurance (
Slide 22: Recognitions
Recognitions Awards National Patient Safety Award in Most Strategic Healthcare Digital Best Investor Relations – the Maternal and Newborn Transformation Partner – Saudi Healthcare – Saudi Arabia 2025 Safety Category Arabia, by International Finance by Global Business Outlook Performance Improvement
Slide 23: Investment Case
Investment Case Attractive Industry Fundamentals HMG is committed to patient safety and wellbeing, providing patients with the highest standards of Adaptable Operating Model medical technology, exceptional patient experiences and sustainability to consistently deliver best-in-class care through its
Slide 24: Appendix #2 Summarized Financials
5 Appendix #2 Summarized Financials
Slide 25: Financial Review
Financial Review Key Financial Information and KPIs FY 2025 FY 2024 Statement of Income million Revenue 13,707 11,200 Gross profit 4,207 3,744 Operating income 2,619 2,356 Profit attributable to equity holders of the parent 2,401 2,315 Balance Sheet million Current assets 5,427 5,319 Non-current ass
Slide 26: Financial Review (Continued)
Financial Review (Continued) Key Financial Information and KPIs FY 2025 FY 2024 Cash Flows million Net cash from operating activities 3,402 2,971 Net cash used in investing activities (2,970) (3,775) Net cash used in financing activities (1,041) 1,075 Cash and Cash Equivalents, Beginning of the Peri
Slide 27: Appendix #3 About HMG
6 Appendix #3 About HMG
Slide 28: About HMG
About HMG HMG continues to elevate healthcare delivery and innovation across the Kingdom and the region. Our reputation for providing personalized subsidiaries positions us at the forefront of patient experience supported by cutting- the industry as we continually seek to edge technology across our
Slide 29: Key Message
Key Message Strategic pillars underpin our drive to deliver best-in-class healthcare services Catalysts for value Best-in-class Efficiency drivers creation • Technology: Pioneer in healthcare • Efficient cash conversion cycle: • Regional integrated healthcare technology, award-winning hospital short
Slide 30: Geographic Footprint
Geographic Footprint Sahafa (Riyadh) Fayhaa (Jeddah) Olaya (Riyadh) Muhammadiyah (Jeddah) Rayan (Riyadh) Qassim Takhassusi (Riyadh) Khobar Suwaidi (Riyadh) Sehat Al Kharj (Kharj) Women’s Health (Riyadh) Dubai Hamra (Riyadh) Tabuk Munsiyah (Riyadh) Jubail (Jubail Industrial City) Dammam Ghadeer (Riya
Slide 31: Geographic Footprint (Continued)
Geographic Footprint (Continued) Our Riyadh Presence MAP KEY Hospital Hospital Under Construction Medical Center Medical Center Under Construction Head Office HMG Academy and Knowledge College Urgent Care FY 2025 HMG Investor Presentation 31
Slide 32: Strategy
Strategy OUR PILLARS Drivers Outcomes Our Growth Strategy Strengthening • Rigorous quality and safety standards • Patient and customer-centric Our forward-thinking corporate strategy creates sustainable value • Top-notch empowered employees value service delivery the Core for our shareholders and st
Slide 33: Business Model
Business Model OUR KEY STRENGTHS WHAT WE DO HMG is uniquely positioned as the leading • Forefront Of Technology and Innovation • Modern Facilities and Comprehensive Services private healthcare group in the region, with the expertise, experience and culture • Trusted Brand in Prime Locations • Sustai
Slide 34: Medical Operation Strategic Pillars
Medical Operation Strategic Pillars Our Fundamental Strategic Pillars Patient Safety Patient Experience Performance and Since its foundation, transformation and evolution, HMG has Enhancing the safety of our Enhancing patient experience by Efficiency always abided by five key strategic pillars that
Slide 35: Pioneer In Healthcare Technology
Pioneer In Healthcare Technology Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) 81 Vida implemented sites Pioneer in healthcare technology, award-winning ▪ Tele-Cardiology (Nabad 24 program): Des
Slide 36: Board of Directors
Board of Directors Non-executives Executives Independents Mr. Faisal Al Nassar Dr. Sulaiman Al Habib Mr. Obaid Al Rasheed Board member, Group CEO and Group Founder and Chairman CFO Vice Chairman Dr. Abdulrahman Mr. Hesham Al Habib Al Turaigi Eng. Saleh Al Habib Board member and Chief Board member Bo
Slide 37: Committee Members
Committee Members Audit Nomination and Remuneration Executive Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Eng. Saleh Al Habib Chairman Chairman Chairman Mr. Turki Al Luhaid Eng. Saleh Al Habib Mr. Faisal Al Nassar Member Member Member Mr. Abdulaziz Al Haidari Mr. Rasheed Al Rasheed Mr. Hesham Al
Slide 38: Executive Management
Executive Management Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Prof. Abdullah Al Herbish Mr. Hesham Al Habib Chief Business Mr. Ahmed Babatin Eng. Abdullah Dr. Riyad Al Atiqi Senior Vice President, Develo
Slide 39: Disclaimer
Disclaimer Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 40: Thank You
Investor Relations Department Thank You King Fahad Road, Olaya District P.O. Box: 91877, Riyadh 11643, Kingdom of Saudi Arabia Phone: + 966 (11) 5259999, Ex. 4919 Fax: + 966 (11) 2174980 Email: investor.relations@drsulaimanalhabib.com OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Dr. Sulaiman Al Habib Medical Services Group (HMG) — FY2025 Earnings Presentation on 6ix